Back to News
Market Impact: 0.3

JNJ Quantitative Stock Analysis

JNJNDAQ
Company FundamentalsAnalyst InsightsHealthcare & BiotechMarket Technicals & FlowsInvestor Sentiment & Positioning
JNJ Quantitative Stock Analysis

Validea's guru fundamental report indicates that Johnson & Johnson (JNJ) receives an 87% rating based on their Multi-Factor Investor model, which is based on the strategy of Pim van Vliet and favors low volatility stocks with strong momentum and high net payout yields; while JNJ passed the market cap and standard deviation tests, it was neutral on momentum and net payout yield, ultimately failing the final rank within this specific strategy.

Analysis

Johnson & Johnson (JNJ) has been highlighted by Validea's guru fundamental report, achieving an 87% rating under its Multi-Factor Investor model, which is based on Pim van Vliet's strategy favoring low volatility, strong momentum, and high net payout yields. This score, which typically signals a degree of interest as it surpasses the 80% threshold, reflects JNJ's status as a large-cap growth stock in the Biotechnology & Drugs industry. The company successfully met the model's criteria for market capitalization and standard deviation, aligning with the strategy's emphasis on low-volatility characteristics. However, JNJ received neutral ratings for both "twelve minus one momentum" and "net payout yield." Crucially, despite the strong initial score and positive volatility metrics, the detailed assessment concluded with a "FAIL" for JNJ on the strategy's "FINAL RANK," indicating that it does not fully satisfy all the explicit conditions required for a definitive endorsement by this particular quantitative investment model.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

strongly positive

Sentiment Score

0.65

Ticker Sentiment

JNJ0.75
NDAQ0.00

Key Decisions for Investors

  • Investors should acknowledge JNJ's favorable characteristics, such as its low volatility and high initial score of 87% under the Pim van Vliet model, but must weigh these against the neutral ratings on momentum and net payout yield, and the critical 'FAIL' on the strategy's final rank.
  • It is prudent to investigate the specific drivers for JNJ's neutral momentum and net payout yield scores to understand its deviation from this specific strategy's ideal profile before making allocation decisions based solely on this model's output.
  • For investors strictly adhering to Pim van Vliet's conservative, multi-factor approach, the 'FAIL' on the final rank suggests JNJ may not be a prime candidate at this time according to this particular screen, despite aligning on key volatility and market cap metrics.